Literature DB >> 27329124

Characterization of patients with aggressive adult T-cell leukemia-lymphoma in Okinawa, Japan: a retrospective analysis of a large cohort.

Yukiko Nishi1, Takuya Fukushima2, Shogo Nomura3, Takeaki Tomoyose1, Sawako Nakachi1, Kazuho Morichika1, Iori Tedokon1, Keita Tamaki1, Natsuki Shimabukuro1, Naoya Taira4, Takashi Miyagi4, Kaori Karimata4, Masayo Ohama4, Atsushi Yamanoha4, Kazumitsu Tamaki5, Masaki Hayashi6, Hitoshi Arakaki7, Jun-Nosuke Uchihara7, Kazuiku Ohshiro8, Yoshitaka Asakura9, Megumi Kuba-Miyara10, Kennosuke Karube11, Hiroaki Masuzaki1.   

Abstract

Okinawa Prefecture, located in the subtropics, is an area of endemic adult T-cell leukemia-lymphoma (ATL) in Japan. We retrospectively analyzed 659 patients with aggressive ATL in seven institutions in Okinawa between 2002 and 2011. The median patient age was 68 years. More patients were aged ≥90 years (2.6 %), in this study, than in a nationwide survey (<1 %). The median survival time (MST) of the entire cohort was 6.5 months. Of the 217 patients who had a clinical status similar to that stated in the eligibility criteria of JCOG9801 (a randomized phase III study comparing VCAP-AMP-VECP with CHOP-14), 147 who received the CHOP regimen had a poorer MST than those in the CHOP-14 arm of JCOG9801 (8 vs 11 months). The prevalence of strongyloidiasis in the ATL patients was much higher (12.4 %) than in the historical cohort who visited the University of the Ryukyus Hospital (3.4 %). Furthermore, strongyloidiasis may be associated with ATL-related deaths. These findings suggest that, compared with other areas in Japan, in Okinawa, the proportion of patients aged ≥90 years with clinical features of aggressive ATL is higher, outcomes are poorer, and the disease is associated with a higher prevalence of strongyloidiasis.

Entities:  

Keywords:  Adult T-cell leukemia–lymphoma; Okinawa; Retrospective analysis; Strongyloidiasis; Subtropics

Mesh:

Substances:

Year:  2016        PMID: 27329124     DOI: 10.1007/s12185-016-2042-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  24 in total

1.  Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study. Lymphoma Study Group (1984-1987).

Authors: 
Journal:  Leuk Res       Date:  1991       Impact factor: 3.156

2.  Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109).

Authors:  Kunihiro Tsukasaki; Kensei Tobinai; Masanori Shimoyama; Mitsuo Kozuru; Naokuni Uike; Yasuaki Yamada; Masao Tomonaga; Koichi Araki; Masaharu Kasai; Kiyoshi Takatsuki; Mitsutoshi Tara; Chikara Mikuni; Tomomitsu Hotta
Journal:  Int J Hematol       Date:  2003-02       Impact factor: 2.490

3.  Monoclonal integration of HTLV-I proviral DNA in patients with strongyloidiasis.

Authors:  K Nakada; K Yamaguchi; S Furugen; T Nakasone; K Nakasone; Y Oshiro; M Kohakura; Y Hinuma; M Seiki; M Yoshida
Journal:  Int J Cancer       Date:  1987-08-15       Impact factor: 7.396

Review 4.  Strongyloides hyperinfection in patients coinfected with HTLV-I and S. stercoralis.

Authors:  K R Phelps
Journal:  Am J Med       Date:  1993-04       Impact factor: 4.965

5.  A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.

Authors:  Y Yamada; M Tomonaga; H Fukuda; S Hanada; A Utsunomiya; M Tara; M Sano; S Ikeda; K Takatsuki; M Kozuru; K Araki; F Kawano; M Niimi; K Tobinai; T Hotta; M Shimoyama
Journal:  Br J Haematol       Date:  2001-05       Impact factor: 6.998

6.  Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression.

Authors:  R C Newton; P Limpuangthip; S Greenberg; A Gam; F A Neva
Journal:  Am J Med       Date:  1992-02       Impact factor: 4.965

7.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.

Authors:  M Yoshida; I Miyoshi; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

8.  The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group.

Authors:  K Tajima
Journal:  Int J Cancer       Date:  1990-02-15       Impact factor: 7.396

9.  Treatment outcome of elderly patients with aggressive adult T cell leukemia-lymphoma: Nagasaki University Hospital experience.

Authors:  Junya Makiyama; Yoshitaka Imaizumi; Hideki Tsushima; Hiroaki Taniguchi; Yuji Moriwaki; Yasushi Sawayama; Daisuke Imanishi; Jun Taguchi; Tomoko Hata; Kunihiro Tsukasaki; Yasushi Miyazaki
Journal:  Int J Hematol       Date:  2014-09-11       Impact factor: 2.490

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  4 in total

1.  Toward a Biology-Driven Treatment Strategy for Peripheral T-cell Lymphoma.

Authors:  Cat Hildyard; S Shiekh; Jab Browning; G P Collins
Journal:  Clin Med Insights Blood Disord       Date:  2017-04-24

2.  An unusual presentation of adult T-cell leukemia/lymphoma.

Authors:  Mohammed Tag-Adeen; Keiichi Hashiguchi; Yuko Akazawa; Ken Ohnita; Sawayama Yasushi; Niino Daisuke; Kazuhiko Nakao
Journal:  Ecancermedicalscience       Date:  2018-01-23

Review 3.  Epidemiology of HTLV-1 Infection and ATL in Japan: An Update.

Authors:  Masako Iwanaga
Journal:  Front Microbiol       Date:  2020-05-29       Impact factor: 5.640

4.  Evaluation of two prognostic indices for adult T-cell leukemia/lymphoma in the subtropical endemic area, Okinawa, Japan.

Authors:  Keita Tamaki; Satoko Morishima; Shogo Nomura; Yukiko Nishi; Sawako Nakachi; Sakiko Kitamura; Sachie Uchibori; Shouhei Tomori; Taeko Hanashiro; Natsuki Shimabukuro; Iori Tedokon; Kazuho Morichika; Naoya Taira; Takeaki Tomoyose; Takashi Miyagi; Kaori Karimata; Masayo Ohama; Atsushi Yamanoha; Kazumitsu Tamaki; Masaki Hayashi; Jun-Nosuke Uchihara; Kazuiku Ohshiro; Yoshitaka Asakura; Megumi Kuba-Miyara; Kennosuke Karube; Takuya Fukushima; Hiroaki Masuzaki
Journal:  Cancer Sci       Date:  2018-06-16       Impact factor: 6.716

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.